Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
918 trades
$10.3T in total
Open-market sales
1,145 trades
$2B in total
Insiders filing
485 insiders
Last 7 days
Amphastar PharmaceuticalsAMPH10b5-1 plan
4,139 sh$103,47509/21Filed 09/21
Rong ZhouVice President
Amphastar PharmaceuticalsAMPH
13,187 sh$290,11409/01Filed 09/01
Amphastar PharmaceuticalsAMPH
47,101 sh$989,12108/18Filed 08/18
Amphastar PharmaceuticalsAMPH
7,973 sh$161,931.6308/11Filed 08/11
Amphastar PharmaceuticalsAMPH10b5-1 plan
8,180 sh$183,886.408/07Filed 08/07
Amphastar PharmaceuticalsAMPH
4,163 sh$333,04025/12/11Filed 25/12/11
Amphastar PharmaceuticalsAMPH
1,737 sh$43,42525/12/10Filed 25/12/10
Amphastar PharmaceuticalsAMPH
20,000 sh$500,00025/11/28Filed 25/11/28
Amphastar PharmaceuticalsAMPH
4,179 sh$104,47525/11/25Filed 25/11/25
Amphastar PharmaceuticalsAMPH
16,679 sh$441,836.7225/11/13Filed 25/11/13
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$12,65025/11/03Filed 25/11/03
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$13,37025/10/01Filed 25/10/01
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$15,45025/09/02Filed 25/09/02
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$10,43025/08/01Filed 25/08/01
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$11,71525/07/02Filed 25/07/02
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$12,80525/06/02Filed 25/06/02
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$12,09525/05/01Filed 25/05/01
Amphastar PharmaceuticalsAMPH10b5-1 plan
500 sh$14,43025/04/01Filed 25/04/01
Amphastar PharmaceuticalsAMPH10b5-1 plan
1,000 sh$27,80025/03/06Filed 25/03/06
Amphastar PharmaceuticalsAMPH10b5-1 plan
4,231 sh$115,125.5125/03/04Filed 25/03/04